Judge OKs $35M Teva Deal In Delayed Generic Inhalers Suit
By Carolyn Muyskens · August 6, 2026, 12:25 PM EDT
A Massachusetts federal judge has approved an antitrust settlement that will see Teva Pharmaceuticals pay $35 million to resolve claims that it schemed to delay generic competition for its QVAR asthma...
To view the full article, register now.